Correlation Between Chia and Elicera Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chia and Elicera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chia and Elicera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chia and Elicera Therapeutics AB, you can compare the effects of market volatilities on Chia and Elicera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chia with a short position of Elicera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chia and Elicera Therapeutics.

Diversification Opportunities for Chia and Elicera Therapeutics

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between Chia and Elicera is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Chia and Elicera Therapeutics AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elicera Therapeutics and Chia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chia are associated (or correlated) with Elicera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elicera Therapeutics has no effect on the direction of Chia i.e., Chia and Elicera Therapeutics go up and down completely randomly.

Pair Corralation between Chia and Elicera Therapeutics

Assuming the 90 days trading horizon Chia is expected to under-perform the Elicera Therapeutics. In addition to that, Chia is 1.47 times more volatile than Elicera Therapeutics AB. It trades about -0.02 of its total potential returns per unit of risk. Elicera Therapeutics AB is currently generating about 0.23 per unit of volatility. If you would invest  167.00  in Elicera Therapeutics AB on October 9, 2024 and sell it today you would earn a total of  22.00  from holding Elicera Therapeutics AB or generate 13.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy80.0%
ValuesDaily Returns

Chia  vs.  Elicera Therapeutics AB

 Performance 
       Timeline  
Chia 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Chia are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical indicators, Chia exhibited solid returns over the last few months and may actually be approaching a breakup point.
Elicera Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Elicera Therapeutics AB are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Elicera Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Chia and Elicera Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chia and Elicera Therapeutics

The main advantage of trading using opposite Chia and Elicera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chia position performs unexpectedly, Elicera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elicera Therapeutics will offset losses from the drop in Elicera Therapeutics' long position.
The idea behind Chia and Elicera Therapeutics AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments